Q32 Bio (QTTB) Total Liabilities (2017 - 2026)

Q32 Bio has reported Total Liabilities for 10 years, with the latest figure at $17.4 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities fell 79.1% year-over-year to $17.4 million; the trailing twelve-month figure through Mar 2026 stood at $17.4 million (down 79.1% YoY), and the FY2025 full-year result was $19.8 million, down 77.2% from the prior year.
• Total Liabilities for Q1 2026 stood at $17.4 million, down from $19.8 million in the prior quarter.
• The five-year high for Total Liabilities was $118.5 million in Q4 2023, with the low at $17.4 million in Q1 2026.
• Average Total Liabilities over 5 years is $64.8 million, with a median of $53.6 million recorded in 2022.
• Year-over-year, Total Liabilities surged 134.76% in 2023 and tumbled 79.1% in 2026.
• Tracing QTTB's Total Liabilities over 5 years: stood at $50.5 million in 2022, then surged by 134.76% to $118.5 million in 2023, then dropped by 26.89% to $86.7 million in 2024, then tumbled by 77.2% to $19.8 million in 2025, then decreased by 12.14% to $17.4 million in 2026.
• The last three Total Liabilities figures came in at $17.4 million (Q1 2026), $19.8 million (Q4 2025), and $76.2 million (Q3 2025), per Business Quant data.

Peer Comparison